Profile data is unavailable for this security.
About the company
CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.
- Revenue in BRL (TTM)11.24bn
- Net income in BRL326.07m
- Incorporated2010
- Employees7.00k
- LocationCM Hospitalar SAAvenida Luiz Maggionin 2.727, Distrito EmpresarialRIBEIRAO PRETO 14.072-055BrazilBRA
- Phone+55 1 121028081
- Websitehttps://ri.viveo.com.br/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natural Health Trends Corp. | 231.25m | 2.68m | 426.60m | 138.00 | 158.65 | 2.02 | 121.70 | 1.84 | 0.0434 | 0.0434 | 3.75 | 3.42 | 0.582 | 2.24 | -- | 311,695.70 | 0.6751 | -0.5398 | 0.9333 | -0.7099 | 74.30 | 74.06 | 1.16 | -0.9571 | 2.77 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
| Balaxi Pharmaceuticals Ltd | 155.26m | -1.54m | 429.62m | 51.00 | -- | 3.27 | -- | 2.77 | -0.566 | -0.566 | 46.75 | 36.96 | 0.969 | 1.37 | 4.47 | -- | -0.9586 | 19.81 | -1.22 | 27.30 | 46.67 | 35.46 | -0.9893 | 11.95 | 2.36 | 26.61 | 0.0879 | -- | -28.28 | 77.76 | -105.19 | -- | 5.11 | -- |
| 111 Inc - ADR | 10.95bn | -277.62m | 497.15m | 1.52k | -- | -- | -- | 0.0454 | -0.6094 | -0.6094 | 24.02 | -1.04 | 4.80 | 9.62 | 32.62 | 1,340,126.00 | -10.93 | -17.09 | -- | -178.25 | 5.56 | 5.36 | -2.28 | -4.37 | 0.5234 | -19.99 | 0.4256 | -- | 10.59 | 52.95 | 5.80 | -- | -7.89 | -- |
| Sopharma Trading AD | 5.09bn | 92.78m | 594.91m | 2.73k | 6.41 | 1.48 | 3.16 | 0.1168 | 0.9201 | 0.9201 | 50.50 | 3.98 | 2.66 | 0.1586 | 7.16 | 661,702.60 | 4.85 | 2.39 | 14.87 | 7.88 | 97.98 | 98.09 | 1.82 | 1.01 | 0.6231 | 185.95 | 0.6107 | -- | 13.02 | 13.26 | 221.67 | 27.86 | 3.70 | -- |
| Pharmaniaga Berhad | 3.97bn | -65.11m | 607.46m | 3.48k | -- | -- | 57.00 | 0.1528 | -0.042 | -0.042 | 2.52 | -0.1888 | 1.67 | 4.91 | 6.10 | 1,003,736.00 | -2.64 | -7.15 | -246.02 | -43.70 | 9.66 | 6.48 | -1.59 | -3.81 | 0.3322 | 1.57 | 1.25 | -- | -2.20 | 7.38 | 87.27 | -- | 28.98 | -- |
| Charmacy Pharmaceutical Co Ltd | 3.26bn | 38.06m | 639.30m | 831.00 | 16.80 | 1.44 | 11.08 | 0.1959 | 0.512 | 0.512 | 43.91 | 5.96 | 1.44 | 6.05 | 4.88 | 5,706,857.00 | 1.68 | 1.79 | 8.28 | 7.99 | 6.34 | 6.08 | 1.17 | 1.24 | 0.7775 | 2.79 | 0.5111 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| Profarma Distribuidora de Produts Frm SA | 8.89bn | 77.11m | 662.40m | 7.08k | 8.51 | 0.5229 | 2.78 | 0.0745 | 0.6289 | 0.6289 | 72.50 | 10.23 | 1.77 | 4.67 | 7.67 | -- | 1.70 | 1.64 | 4.06 | 3.40 | 14.97 | 14.61 | 0.9618 | 0.9519 | 0.7696 | 1.85 | 0.4552 | -- | 10.82 | 15.19 | -12.95 | -- | 41.08 | -- |
| CM Hospitalar SA | 11.24bn | 326.07m | 690.84m | 7.00k | 2.07 | 0.2074 | 1.15 | 0.0615 | 1.04 | 1.04 | 36.93 | 10.32 | 1.12 | 5.56 | 4.67 | 1,606,019.00 | 3.25 | 4.00 | 4.51 | 6.15 | 15.13 | 15.89 | 2.90 | 3.50 | 1.68 | 1.56 | 0.576 | -- | 26.72 | 33.22 | 38.57 | 60.22 | -2.72 | -- |
| EQL Pharma AB | 135.12m | 11.61m | 764.08m | 21.00 | 67.26 | 8.41 | -- | 5.66 | 0.7642 | 0.7642 | 8.88 | 6.12 | 0.8012 | 1.74 | 4.80 | 12,579,430.00 | 6.89 | 9.02 | 11.90 | 15.27 | 43.55 | 37.95 | 8.59 | 8.29 | 0.5694 | 8.88 | 0.4032 | -- | 1.64 | 39.64 | -26.57 | -- | 32.73 | -- |
| Hemas Holdings PLC | 2.15bn | 108.06m | 907.78m | 5.83k | 8.40 | 1.18 | 6.38 | 0.4219 | 10.24 | 10.24 | 203.85 | 72.79 | 1.27 | 3.33 | 4.70 | 20,874,320.00 | 6.61 | 5.71 | 12.51 | 10.41 | 29.60 | 29.36 | 5.23 | 4.94 | 1.01 | 5.01 | 0.2236 | 28.30 | 6.74 | 13.67 | 43.10 | 12.64 | -2.33 | 13.12 |
Data as of Jun 14 2024. Currency figures normalised to CM Hospitalar SA's reporting currency: Brazilian Real BRL
27.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dynamo Administra��o de Recursos Ltda.as of 23 May 2024 | 32.46m | 10.05% |
| GIC Pte Ltd. (Investment Management)as of 10 Jan 2023 | 28.62m | 8.87% |
| Verde Asset Management SAas of 29 Feb 2024 | 8.20m | 2.54% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 5.63m | 1.74% |
| BTG Pactual WM Gest�o de Recursos Ltda.as of 29 Feb 2024 | 3.70m | 1.15% |
| Nucleo Capital Ltda.as of 30 Apr 2023 | 3.54m | 1.10% |
| Fidelity Management & Research Co. LLCas of 30 Apr 2024 | 3.21m | 1.00% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 06 Jun 2024 | 1.90m | 0.59% |
| Velt Partners Investimentos Ltdaas of 30 Apr 2023 | 1.59m | 0.49% |
| Sharp Capital Gestora de Recursos Ltda.as of 29 Feb 2024 | 994.42k | 0.31% |
More ▼
Data from 30 Sep 2023 - 04 Jun 2024Source: FactSet Research Systems Inc.
